
From Salk Institute discovery to patient care: Vitamin D analog shuts down pancreatic cancer’s shield in clinical trial
<a href="https://news.google.com/rss/articles/CBMi5wFBVV95cUxPNTM0Y2FLX1lBcWNJWUg5ZGpyMVAxd0NRQnRPWGx5Z3lRNFY2R3B1RFRpRUQyYTI4RTE0cllqRUdIMGliNjZ6T2tIZVdjeFZKcEtnbUxXam92TkE3ZHZJU2ttSzdtc1h6WGZFN1NqOVUtcGFka3FDTlI2c1VXV0daN1JTYUJiVU42Znhxbm10dFFMWllGS0xxRExUamxQRFRkZG9rc1lmajBTcUlrY0w5Slg0MHRWV25PVzdvVE1zWW54ZFZkUUI1bWVXdnNudGRhanFDdzhEakVQSDJxMWZyVVlDTjBXeTA?oc=5" target="_blank">From Salk Institute discovery to patient care: Vitamin D analog shuts down pancreatic cancer’s shield in clinical trial</a>&nbsp;&nbsp;<font color="#6f6f6f">Salk Institute</font>
